UPSHER-SMITH LAUNCHES NEW ONLINE RESOURCES TO SUPPORT THE DUCHENNE COMMUNITY
Caregiver and Healthcare Professional Platforms Provide Resources for Initiating and Managing KYMBEEâ„¢ (deflazacort) Tablets Treatment
UPSHER-SMITH LAUNCHES GENERIC VERSION OF CIPRODEX® (CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1%) STERILE OTIC SUSPENSION
First Prescription Ear Drop Suspension Advances Portfolio Diversification Strategy
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
Bora manufactures more than 20 commercial products for GSK at its Mississauga facility, supporting infectious disease, mental health, dermatology, & other critical therapeutic areas
OTC Markets Group Welcomes Bora Pharmaceuticals Co., Ltd. to OTCQX
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Bora Pharmaceuticals...